Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe

AIDS Patient Care and STDs

Volumn 23, Issue 7, 2009, Pages 571-576

  Pascoe, Sophie J S ^a   Langhaug, Lisa F ^b   Mudzori, James ^c   Burke, Eileen ^d   Hayes, Richard ^a   Cowan, Frances M ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c National Microbiology Reference Laboratory   (Zimbabwe)

^d Comforce/CDC Zimbabwe ^*  (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COUNSELING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIELD STUDY; GOLD STANDARD; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; ORAL FLUID RAPID TEST; OUTPATIENT DEPARTMENT; PREVALENCE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; WESTERN BLOTTING; ZIMBABWE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS SERODIAGNOSIS; ALGORITHMS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REAGENT KITS, DIAGNOSTIC; RURAL POPULATION; SALIVA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT; ZIMBABWE;

EID: 69249119007     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0225     Document Type: Article

References (36)

1. UNAIDS/WHO. Operational characteristics of commercially available assays to determine antibodies to HIV-1 and/or HIV-2 in human sera (Report 11) 1999.
2. UNAIDS/WHO. HIV Assays: Operational characteristics (Phase 1) Simple/rapid tests whole blood specimens (Report 12) 2002.
3. World Health Organization. Guidelines for Using HIV Testing Technologies in Surveillance: Selection, Evaluation and Implementation. Geneva, Switzerland: World Health Organizaton, 2001,
4. Gregson S, Zhuwau T, Ndlovu J, Nyamukapa CA. Methods to reduce social desirability bias in sex surveys in low-development settings: Experience in Zimbabwe. Sex Transm Dis 2002;29:568-575.
5. Delaney KP, Branson BM, Uniyal A, et al. Performance of an oral fluid rapid HIV-1/2 test: Experience from four CDC studies. AIDS 2006;20:1655-1660. (Pubitemid 44162408)
6. Pant Pai N. Oral fluid-based rapid HIV testing: Issues, challenges and research directions. Expert Rev Mol Diagn. Jul 2007;7:325-328.
7. Pai NP, Barick R, Tulsky JP, et al. Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med 2008;5:e92. (Pubitemid 351760906)
8. Branson BM. State of the art for diagnosis of HIV infection. Clin Infect Dis 2007;45(Suppl 4):S221-225.
9. Branson BM. FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids. AIDS Clin Care 2004;16:39.
10. Pant Pai N, Joshi R, Dogra S, et al. Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS ONE 2007;2:e367.
11. Centers for Disease Control and Prevention. False-positive oral fluid rapid HIV tests - New York City, 2005-2008. MMWR Morb Mortal Wkly Rep 2008;57:660-665.
12. Wesolowski LG, MacKellar DA, Facente SN, et al. Postmarketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006;20:1661-1666.
13. Jafa K, Patel P, Mackellar DA, et al. Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS ONE 2007;2:e185.
14. Roberts KJ, Grusky O, Swanson AN. Outcomes of blood and oral fluid rapid HIV testing: A literature review, 2000-2006. AIDS Patient Care STDs 2007;21:621-637.
15. Pai NP, Tulsky JP, Cohan D, Colford JM, Jr., Reingold AL. Rapid point-of-care HIV testing in pregnant women: A systematic review and meta-analysis. Trop Med Int Health 2007;12:162-173. (Pubitemid 46244172)
16. Collini P. Diagnosing HIV: Oral fluid HIV tests - Diagnostic accuracy and patient acceptability. BMJ Clin Evid 2006:1-12.
17. Akanmu AS, Akinsete I, Adesemoye EF, Okany CC. Evaluation of saliva-based diagnostic test kit for routine detection of antibodies to HIV. Afr J Med Med Sci. Dec 2001;30:305-308.
18. Erhabor O, Uko EK, Buseri FI, Adias TC. Comparative study of oral fluid and serum based enzyme immunoassay in the diagnosis of HIV in Nigeria. J Hellenic Soc Haematol 2005;8:615-618. (Pubitemid 41571566)
19. Talbot EA, Hone NM, Moffat HJ, et al. The validity of HIV testing using sputum from suspected tuberculosis patients, Botswana, 2001. Int J Tuberc Lung Dis 2003;7:710-713.
20. Sherman GG, Jones SA. Oral fluid human immunodeficiency virus tests: Improved access to diagnosis for infants in poorly resourced prevention of mother to child transmission programs. Pediatr Infect Dis J 2005;24:253-256.
21. Hamers RL, de Beer IH, Kaura H, van Vugt M, Caparos L, Rinke de Wit TF. Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in Namibia. J. Acquir Immune Defic Syndr 2008;48:116-118. (Pubitemid 351600849)
22. Cowan FM, Pascoe SJ, Langhaug LF, et al. The Regai Dzive Shiri Project: A cluster randomised controlled trial to determine the effectiveness of amulti-component community-based HIV prevention intervention for rural youth in Zimbabwe - Study design and baseline results. Trop Med Int Health 2008; 13:1235-1244.
23. Orasure Technologies Inc. OraQuick ADVANCE Rapid HIV1/2 antibody test product insert. www.orasure.com/uploaded/398.pdf (Last accessed February 25, 2008).
24. US National Committee for Clinical Laboratory Standards. Blood Collection on Filter Paper for Neonatal Screening Programs (LA4A). www.csli.org. (Last accessed February 25, 2008.
25. US Department of Health and Human Services. Serologic assays for human immunodeficiency virus antibody in dried blood specimens collected on filter paper. 2000.
26. Department Of Health and Human Services/Centers for Disease Control and Prevention. Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa. Atlanta, GA: 2002.
27. UNAIDS/WHO. HIV assays: Operational characteristics (Phase 1): antigen/antibody ELISAs (Report 15) 2004.
28. UNAIDS/WHO. HIV Assays: Operational Characteristics (Phase 1) Simple/Rapid tests (Report 14) 2004.
29. Debattista J, Bryson G, Roudenko N, et al. Pilot of noninvasive (oral fluid) testing for HIV within a clinical setting. Sex Health 2007;4:105-109. (Pubitemid 46809025)
30. Holm-Hansen C, Nyombi B, Nyindo M. Saliva-Based HIV Testing among Secondary School Students in Tanzania using the OraQuick(R) Rapid HIV1/2 Antibody Assay. Ann NY Acad Sci 2007;1098:461-466. (Pubitemid 47092557)
31. Peralta L, Constantine N, Griffin Deeds B, Martin L, Ghalib K. Evaluation of youth preferences for rapid and innovative human immunodeficiency virus antibody tests. Arch Pediatr Adolesc Med 2001;155:838-843. (Pubitemid 32613789)
32. Spielberg F, Branson BM, Goldbaum GM, et al. Choosing HIV Counseling and testing strategies for outreach settings: A randomized trial. J Acquir Immune Defic Syndr 2005;38: 348-355. (Pubitemid 40333503)
33. Central Statistical Office (CSO) [Zimbabwe] and Macro International Inc. Zimbabwe Demographic and Health Survey 2005-2006 2007.
34. Ministry of Health and Child Welfare (Zimbabwe), Zimbabwe National Family Planning Council, National AIDS Council (Zimbabwe), US Centers for Disease Control and Prevention. The Zimbabwe Young Adult Survey (YAS) 2001-2002 Final Report. 2004.
35. O'Connell RJ, Merritt TM, Malia JA, et al. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol 2003;41:2153-2155.
36. Orasure Technologies Inc. Orasure HIV-1 Oral Specimen Collection Device. www.orasure.com/products/default.asp? sec=2&subx=2&cid=2&prd=133 (Last accessed June 18, 2008).